TXNIP Regulates Peripheral Glucose Metabolism in Humans

DSpace/Manakin Repository

TXNIP Regulates Peripheral Glucose Metabolism in Humans

Citable link to this page


Title: TXNIP Regulates Peripheral Glucose Metabolism in Humans
Author: Parikh, Hemang; Carlsson, Emma; Johansson, Lovisa E; Storgaard, Heidi; Poulsen, Pernille; Ladd, Christine; Schulze, P. Christian; Mazzini, Michael J; Jensen, Christine Bjørn; Krook, Anna; Björnholm, Marie; Tornqvist, Hans; Zierath, Juleen R; Ridderstråle, Martin; Vaag, Allan; Groop, Leif C; Chutkow, William Alexander; Saxena, Richa; Altshuler, David Matthew; Lee, Richard Theodore; Mootha, Vamsi Krishna

Note: Order does not necessarily reflect citation order of authors.

Citation: Parikh, Hemang, Emma Carlsson, William A. Chutkow, Lovisa E. Johansson, Heidi Storgaard, Pernille Poulsen, Richa Saxena, et al. 2007. TXNIP Regulates Peripheral Glucose Metabolism in Humans. PLoS Medicine 4(5): e158.
Full Text & Related Files:
Abstract: Background: Type 2 diabetes mellitus (T2DM) is characterized by defects in insulin secretion and action. Impaired glucose uptake in skeletal muscle is believed to be one of the earliest features in the natural history of T2DM, although underlying mechanisms remain obscure. Methods and Findings: We combined human insulin/glucose clamp physiological studies with genome-wide expression profiling to identify thioredoxin interacting protein (TXNIP) as a gene whose expression is powerfully suppressed by insulin yet stimulated by glucose. In healthy individuals, its expression was inversely correlated to total body measures of glucose uptake. Forced expression of TXNIP in cultured adipocytes significantly reduced glucose uptake, while silencing with RNA interference in adipocytes and in skeletal muscle enhanced glucose uptake, confirming that the gene product is also a regulator of glucose uptake. TXNIP expression is consistently elevated in the muscle of prediabetics and diabetics, although in a panel of 4,450 Scandinavian individuals, we found no evidence for association between common genetic variation in the TXNIP gene and T2DM. Conclusions: TXNIP regulates both insulin-dependent and insulin-independent pathways of glucose uptake in human skeletal muscle. Combined with recent studies that have implicated TXNIP in pancreatic β-cell glucose toxicity, our data suggest that TXNIP might play a key role in defective glucose homeostasis preceding overt T2DM.
Published Version: doi:10.1371/journal.pmed.0040158
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1858708/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:4878922
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)


Search DASH

Advanced Search